ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Revelation Biosciences Inc

Revelation Biosciences Inc (REVB)

2,95
0,19
(6,88%)
À la fermeture: 19 Mars 9:00PM
2,95
0,00
( 0,00% )
Après les heures de négociation: 9:30PM

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

Dernier
2,95
Prix Achat
2,91
Prix Vente
3,00
Volume échangé
48 667
2,70 Fourchette du Jour 3,13
2,36 Plage de 52 semaines 60,80
Cap du marché
Clôture Veille
2,76
Ouverture
2,70
Dernière Transaction
1
@
2.95
Dernière heure de transaction
21:05:09
Volume financier
US$ 144 494
VWAP
2,969
Volume moyen (3 m)
2 604 506
Actions en circulation
905 228
Rendement du Dividende
-
Ratio Cours sur Bénéfices
0,00
Bénéfice par action (BPA)
-16,61
Chiffre d'affairess
-
Bénéfice net
-15,04M

À propos de Revelation Biosciences Inc

Revelation Biosciences Inc is a clinical-stage life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease. It has several product candidates in development. REVTx-99, the lead therapeutic candidate, is an intranasal immunomodulator to ... Revelation Biosciences Inc is a clinical-stage life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease. It has several product candidates in development. REVTx-99, the lead therapeutic candidate, is an intranasal immunomodulator to prevent or treat infections caused by various respiratory viruses such as SARS-CoV-2, including its variants, influenza A and B, parainfluenza, rhinovirus, and RSV. REVTx-99 is also being developed for other indications such as: allergic rhinitis and chronic nasal congestion. REVTx-200 is an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for more complete immunity. REVTx-200 is based on the same technology used in REVTx-99. Show more

Secteur
Pharmaceutical Preparations
Industrie
Blank Checks
Siège social
Lewes, Delaware, USA
Fondé
2022
Revelation Biosciences Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker REVB. Le dernier cours de clôture d'Revelation Biosciences était de US$2,76. Au cours de la dernière année, les actions de Revelation Biosciences ont été négociées dans une fourchette de prix de US$ 2,36 à US$ 60,80.

Revelation Biosciences compte actuellement 905 228 actions en circulation. La capitalisation boursière d'Revelation Biosciences est de US$2,50 million. Revelation Biosciences a un ratio cours/bénéfice (ratio PE) de 0.00.

REVB Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.415-12.33283803863.3653.472.364770122.99783304CS
4-1.44-32.80182232354.394.542.361734293.19876106CS
12-2.5636-46.49593731865.513620.162.3626045069.57531322CS
26-10.938-78.75864055313.88820.162.36171213410.45106258CS
52-34.97-92.22046413537.9260.82.36140912019.61531924CS
156-28557.05-99.989670868328560483842.3612925538119.83508918CS
260-140781.05-99.99790459141407841638002.36135944410667.0121343CS

REVB - Frequently Asked Questions (FAQ)

What is the current Revelation Biosciences share price?
The current share price of Revelation Biosciences is US$ 2,95
How many Revelation Biosciences shares are in issue?
Revelation Biosciences has 905 228 shares in issue
What is the market cap of Revelation Biosciences?
The market capitalisation of Revelation Biosciences is USD 2,5M
What is the 1 year trading range for Revelation Biosciences share price?
Revelation Biosciences has traded in the range of US$ 2,36 to US$ 60,80 during the past year
What is the reporting currency for Revelation Biosciences?
Revelation Biosciences reports financial results in USD
What is the latest annual profit for Revelation Biosciences?
The latest annual profit of Revelation Biosciences is USD -15,04M
What is the registered address of Revelation Biosciences?
The registered address for Revelation Biosciences is 16192 COASTAL HWY, LEWES, DELAWARE, 19958
Which industry sector does Revelation Biosciences operate in?
Revelation Biosciences operates in the BLANK CHECKS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
IMGCIMG Inc
US$ 0,62
(29,17%)
1,26M
AGHAureus Greenway Holdings Inc
US$ 1,00
(24,22%)
3,2M
LGHLLion Group Holding Ltd
US$ 0,1115
(17,49%)
1,17M
CMLSCumulus Media Inc
US$ 0,508
(13,60%)
4,99k
AIEVThunder Power Holdings Inc
US$ 0,2046
(13,35%)
398,61k
AKBAAkebia Therapeutics Inc
US$ 2,29
(-19,37%)
705,75k
LSELeishen Energy Holding Company Ltd
US$ 11,05
(-11,60%)
66,19k
PITAHeramba Electric PLC
US$ 0,2451
(-7,51%)
77,85k
BONBon Natural Life Ltd
US$ 0,325
(-7,22%)
1,17M
HEPAHepion Pharmaceuticals Inc
US$ 0,7701
(-6,09%)
178,4k
XHLDTEN Holdings Inc
US$ 1,58
(-0,63%)
4,97M
IQiQiyi Inc
US$ 2,48
(0,00%)
4,24M
MARAMARA Holdings Inc
US$ 12,56
(0,24%)
3,22M
AGHAureus Greenway Holdings Inc
US$ 1,00
(24,22%)
3,2M
SCZiShares MSCI EAFE Small Cap
US$ 66,08
(0,00%)
2,9M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock